Institutional shares held 3.57 Billion
71.5M calls
96.1M puts
Total value of holdings $92.8B
$1.86B calls
$2.5B puts
Market Cap $146B
5,612,349,952 Shares Out.
Institutional ownership 63.6%
# of Institutions 3,171

Latest Institutional Activity in PFE

Top Purchases

Q1 2024
Amf Tjanstepension Ab Shares Held: 1.23M ($31.9M)
Q1 2024
Welch Group, LLC Shares Held: 1.49M ($38.8M)
Q1 2024
Norden Group LLC Shares Held: 581K ($15.1M)
Q1 2024
Wealthfront Advisers LLC Shares Held: 604K ($15.7M)
Q1 2024
Banque Cantonale Vaudoise Shares Held: 470K ($12.2M)

Top Sells

Q1 2024
Aegon Asset Management Uk PLC Shares Held: 4.28K ($111K)
Q1 2024
Allspring Global Investments Holdings, LLC Shares Held: 1.6M ($41.5M)
Q1 2024
Brookstone Capital Management Shares Held: 89K ($2.31M)
Q1 2024
Wealth Enhancement Advisory Services, LLC Shares Held: 1.63M ($42.3M)
Q1 2024
Fundamentun, LLC Shares Held: 15.4K ($400K)

About PFE

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Insider Transactions at PFE

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
From 12 Insiders
Exercise of conversion of derivative security 360K shares
Grant, award, or other acquisition 141K shares
Open market or private purchase 5K shares
Sell / Disposition
From 10 Insiders
Payment of exercise price or tax liability 402K shares

Related Articles

Track Institutional and Insider Activities on PFE

Follow PFIZER INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PFE shares.

Notify only if

Insider Trading

Get notified when an Pfizer Inc insider buys or sells PFE shares.

Notify only if


Receive news related to PFIZER INC

Track Activities on PFE